Glenmark completes phase 3 study for nasal spray Ruby Khatun Khatun15 Dec 2017 4:45 AM GMTNew Delhi: Glenmark Pharmaceuticals said it has completed phase 3 study of its investigational fixed-dose combination nasal spray and plans to submit...
Hetero gets DCGI nod to market anti-retroviral FDC tablets Ruby Khatun Khatun17 Nov 2017 5:15 AM GMTNew Delhi: Drug firm Hetero said it has received the Drug Controller General of India's approval to launch generic fixed-dose combination...
Mylan Launches Avonza in India for HIV Ruby Khatun Khatun10 Aug 2017 4:30 AM GMTHERTFORDSHIRE, England and PITTSBURGH: Mylan Pharmaceuticals Private Limited, a subsidiary of Mylan N.V., a leading global pharmaceutical company, has...
Big Relief to Pharma Companies: Delhi HC quashes ban on FDC drugs Meghna A Singhania1 Dec 2016 8:38 AM GMTNew Delhi: In a move that would bring great relief to pharmaceutical companies across the country, the Delhi High Court has set aside the government...
